Suzhou Zelgen Biopharmaceuticals Co., Ltd. logo

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266)

Market Open
10 Aug, 06:57
SSE SSE
¥
119. 55
-2.15
-1.7666%
¥
21.56B Market Cap
- P/E Ratio
- Div Yield
9.13M Volume
- Eps
¥ 121.7
Previous Close
Add Transaction
Day Range
117.8 127.74
Year Range
75.1 160
Want to track 688266 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Suzhou Zelgen Biopharmaceuticals Co., Ltd. logo
688266 Suzhou Zelgen Biopharmaceuticals Co., Ltd.
20 Apr 2026
-
-
Suzhou Zelgen Biopharmaceuticals Co., Ltd. logo
688266 Suzhou Zelgen Biopharmaceuticals Co., Ltd.
28 Mar 2026
-
-
Suzhou Zelgen Biopharmaceuticals Co., Ltd. logo
688266 Suzhou Zelgen Biopharmaceuticals Co., Ltd.
25 Oct 2024
-
-
Suzhou Zelgen Biopharmaceuticals Co., Ltd. logo
688266 Suzhou Zelgen Biopharmaceuticals Co., Ltd.
19 Apr 2024
-
-
Suzhou Zelgen Biopharmaceuticals Co., Ltd. logo
688266 Suzhou Zelgen Biopharmaceuticals Co., Ltd.
23 Feb 2024
-
-
Suzhou Zelgen Biopharmaceuticals Co., Ltd. logo
688266 Suzhou Zelgen Biopharmaceuticals Co., Ltd.
27 Oct 2023
-
-

688266 Earnings Reports FAQ

What is the earnings per share (EPS) for 688266?

EPS data for 688266 is currently not available, as Suzhou Zelgen Biopharmaceuticals Co., Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Suzhou Zelgen Biopharmaceuticals Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Suzhou Zelgen Biopharmaceuticals Co., Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Suzhou Zelgen Biopharmaceuticals Co., Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 688266 at this time, as Suzhou Zelgen Biopharmaceuticals Co., Ltd has no recent EPS data to calculate it.